Schedule a meeting:

Syngene International Ltd. is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. With a combination of dedicated research facilities for Amgen and Bristol-Myers Squibb and 2.2 Mn sq. ft of specialist discovery, development and manufacturing facilities, Syngene works with biotech companies pursuing leading-edge science as multinationals including GSK, Zoetis, and Merck KGaA.

© Syngene International Ltd.
Syngene International Ltd. Biocon Park, SEZ, Bommasandra Industrial Area - Phase - IV, Bengaluru 560099 India.

The Syngene advantage

• A global CRO/CDMO offering integrated drug discovery, development, and manufacturing services across small molecules, biologics, oligonucleotides, and ADCs
• IP that can be fully assigned to clients
• Strong track record of data integrity and security with over 400+ patent assignments by clients recognizing Syngene
• Quality-driven organization with US FDA, EMA, and PMDA approved, GLP-certified, AAALAC-accredited facilities
• Scientific eco-system of 2.2 Mn sq. ft. world-class R&D and manufacturing infrastructure, ~5200 qualified scientists, and highly effective supply chain practices
• Biologics manufacturing capacity of 28,000L and small molecule capacity of 70,000L
• 400+ active clients with delivery history for integrated CMC programs towards first-in-human studies and beyond